Genome Research: Fulfilling the Public's Expectations for Knowledge and Commercialization
- 14 August 1992
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 257 (5072) , 908-914
- https://doi.org/10.1126/science.1502557
Abstract
This article provides a historical perspective for the patenting of gene sequences and describes the fundamentals and evolution of patent law. It summarizes federal technology transfer law and policy and assesses the impacts of patenting on academic research. The patentability of gene sequences is then considered along with potential impacts that published sequence data may have on obtaining patent protection for downstream products. Industry's position on gene patenting is summarized and perspectives from the emerging public record on these issues are presented. The article discussing points at which the filing of patent applications and the licensing of patents may be appropriate. It concludes that technology transfer policies for genome research must be adopted carefully so that they remain viable in a time of rapid technological change.Keywords
This publication has 11 references indexed in Scilit:
- On Gene PatentingNew England Journal of Medicine, 1992
- The Race for the "Gold" in ResearchScience, 1992
- Sequence identification of 2,375 human brain genesNature, 1992
- The Human Genome Project and PatentsScience, 1991
- Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome ProjectScience, 1991
- Are Prescription Drug Prices High?Science, 1991
- On the Complex Economics of Patent ScopeColumbia Law Review, 1990
- Patents and the Progress of Science: Exclusive Rights and Experimental UseThe University of Chicago Law Review, 1989
- Biotechnology as an Intellectual PropertyScience, 1984
- Foreign Trade and U. S. Research and DevelopmentThe Review of Economics and Statistics, 1979